Gate2Brain receives €2.5 million in funding to develop a technology that facilitates the delivery of drugs to the brain

Gate2Brain, spin-off of the IRB Barcelona, ​​the UB and the SJD, receives 2.5 million euros in funding to develop a technology that facilitates the delivery of drugs to the brain. The aid has been received through the EIC Accelerator program, which will contribute to promoting the regulatory preclinical phase of its drug G2B-002, aimed at brain tumors with an intact barrier, which it carries out together with Hospital Sant Joan de Déu. In 2 or 3 years these results will open the doors to a clinical trial.

“Man has dreamed of traveling to the brain for decades and, in fact, science fiction has dedicated books and films such as Isaac Asimov’s Fantastic Voyage. Gate2Brain’s dream is to improve the health and quality of life of people suffering from central nervous system diseases by improving drug delivery to the brain and treating it” says Teixidó. She also adds that “today, just before Christmas, that dream is one step closer thanks to funding from the EIC Accelerator.”

EIC Accelerator is a program of the European Innovation Council (EIC) that supports individual Small and Medium Enterprises (SMEs), in particular Startups and spin-offs, to develop and scale breakthrough innovations.

EIC Acceleration selected 78 innovative companies from among 1,092 startups and SMEs, of which 240 were interviewed by a panel of experienced investors and entrepreneurs. The selected companies will together receive close to €470 millions of funding in a combination of grants and equity investments. The program covers a geographical distribution of 17 countries and is characterized by the fact that 15% of companies are headed by women.

Gate2Brain is a spin-off of the Barcelona Biomedical Research Institute (IRB Barcelona), the University of Barcelona (UB) and the Sant Joan de Déu Research Institute (SJD). Created in July 2020, thanks to the financial boost received from the Fundación Botín -through the Mind the Gap program-, Banco de Sabadell -through BStartup Health, and “la Caixa” Foundation -through CaixaResearch Consolidate-, and later the NEOTEC Program of the Center for Industrial Technological Development (CDTI).

Share this post:

Utilitzem cookies de tercers amb finalitats tècniques i analítiques. Si continua navegant vol dir que accepta la nostra política de cookies. Més informació,plugin cookies política de cookies.

Aviso de cookies